First Efficacy Trials on Switch to RPV/FTC/TAF for HIV Yield Positive Results
September 19th 2018Switching to the smallest complete daily pill for HIV from other regimens with different components of the same drug classes proved advantageous for patients with HIV, treating the infection with less adverse effects.
Read More